# LIDOCAINE HYDROCHLORIDE
> **ANDA218676** · Abbreviated New Drug Application (Generic) · Sponsor: QUAGEN · Approved 2026-03-20
## Drug
- **FDA Application Number:** ANDA218676
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LIDOCAINE HYDROCHLORIDE
- **Generic name:** Lidocaine Hydrochloride
- **Active ingredients:** LIDOCAINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** QUAGEN
- **First approval:** 2026-03-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218676)
---
*AI Analytics · CC0 1.0*